China Slashing Tariffs on 925 Key Products in 2026 to Boost Tech and Bio-Medical Sectors

China has officially announced a significant reduction in import tariffs for 925 products effective early 2026, a strategic move aimed at accelerating industrial growth and securing critical supply chains. The Customs Tariff Commission of the State Council highlighted that these adjustments focus on high-tech raw materials, such as recycled black powder for lithium-ion batteries, and essential medical technologies, including artificial blood vessels and infectious disease diagnostic equipment.

By setting these temporary tariff rates below the Most-Favored-Nation (MFN) standards, Beijing is signaling a commitment to a more open trade policy amidst global economic shifts. This initiative is designed to lower production costs for domestic manufacturers in the green energy and healthcare sectors while enhancing China’s attractiveness to foreign investors. Experts view this as a pivotal step in China’s five-year plan to lead in global innovation and self-reliance within the high-end technology and medical infrastructure industries.